Structure Therapeutics Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureSep 8 →InsidersNo open-market buys or sales.→HoldersFMR 3.7%Wellington Management Group LLP 3.5%Avoro Capital 3.1%→Financing →PeersClosest companies: SEPN, MBX, BCYC→
From the filings
Figures
- Net income
- −$214.8Mlast 12 months
- Operating cash flow
- −$154.7Mlast 12 months
- Cash and equivalents
- $272.6Mat the last balance sheet
- Shares outstanding
- 213.7M shareson issue